Background:
Concerns on the safety of polio vaccine in some parts of northern Nigeria that led to the suspension of the immunization efforts in those parts of the country, informed our design of this prospective study.
Shiraz E-Medical Journal
Concerns on the safety of polio vaccine in some parts of northern Nigeria that led to the suspension of the immunization efforts in those parts of the country, informed our design of this prospective study.
To determine polio-specific Immunoglobulin G antibodies among children (seven months - seven years) in Jos.
Within the months of March and April 2007, One hundred and eighty two blood samples were collected from children in the Emergency Peadiatric Unit of the Jos University Teaching Hospital and tested for the presence of polio-specific IgG antibodies using Poliomyelitis IgG ELISA Test Kit produced and described by DEMEDITEC Diagnostic GmbH Germany
One hundred and seventy eight percent (97.8%) of the tested children had detectable antibodies against poliovirus. The study population had appreciable levels of protection against poliovirus. There was no significant association between the detection of the IgG in children in relation to gender, age, religion, and number of doses. Only educational status of fathers had statistically significant relationship with the detection of the antibodies.
This study demonstrated that progress has been made towards the eradication of poliomyelitis in Nigeria. To further strengthen the gains made and weaken the barriers to immunization, there is an increasing need for more funding to increase awareness and intensify the final efforts targeted at kicking polio out of Nigeria.
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Rafiei Tabatabaei S, Karimi A, Alebouyeh M, Zahed G, Faghihian E, et al. Seroprevalence of Measles and Rubella IgG Antibodies in Children and Pregnant Women in Iran. Arch Pediatr Infect Dis. 2024;12(2):e140365. doi: https://doi.org/10.5812/apid-140365
Adabara Nasiru U. Assessment of Maternofoetal Transfer of Antitetanus Immunoglobulin G in Jos University Teaching Hospital (JUTH), Jos. Shiraz E-Med J. 1970;11(2):20365. doi:
Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, et al. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination. Jundishapur J Microbiol. 2012;5(4):578-581. doi: https://doi.org/10.5812/jjm.4563
Arjmand R, Gholami M, Shirvani F, Pourrostami K, Safari O, et al. Hepatitis B Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Local Study in Alborz Province, Iran, 2016. Arch Pediatr Infect Dis. 2019;7(2):e83565. doi: https://doi.org/10.5812/pedinfect.83565
Shakurnia A, Alavi SM, Norouzirad R, Sarajian AA, Shakerinejad G. Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran. Jundishapur J Microbiol. 2013;6(10):e7707. doi: https://doi.org/10.5812/jjm.7707
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC